The determination of nicotinic acid in plasma by mixed-mode liquid chromatography-tandem mass spectrometry following

D N Mallett1, S Dayal, G J Dear

  • 1Drug Metabolism and Pharmacokinetics, Cardiovascular and Urogenital Centre of Excellence in Drug Discovery, GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage, Herts, UK. dave.n.mallett@gsk.com